Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to collect and evaluate real-world data on the effectiveness of deucravacitinib treatment in adults with moderate plaque psoriasis in China.
Official title: A Prospective Observational Study to Evaluate the Effectiveness of Deucravacitinib in Patients With Moderate Plaque Psoriasis in Real-World Settings in China (ADMIRE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
153
Start Date
2025-01-20
Completion Date
2027-03-11
Last Updated
2026-04-15
Healthy Volunteers
No
Conditions
Interventions
Deucravacitinib
As per product label
Locations (5)
Local Institution - 0001
Guangzhou, Guangdong, China
Local Institution - 0002
Handan, Hebei, China
Local Institution - 0005
Dalian, Liaoning, China
Local Institution - 0004
Shanghai, Shanghai Municipality, China
Local Institution - 0003
Beijing, China